Quote:

---

Say a person has multiple issues, let’s say long haulers, prostatis and let’s throw something in there baldness (since it’s recently been talked about).

Do you think patients with multiple indications would change the dosage, or would it be more genetically driven?

---

I think any lesser dosage for an indication would be based on the severity of symptoms rather than the indication itself. In most cases I think 700mg would be the way to go to get to a homeostatic immune response since we know other receptors will be still responding in an elevated manner. In diseases that inflammation or autoimmune response can vary 525mg or 350mg may have enough effect in less severe cases.